YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Evaluation of Hematologic and Biochemical Parameters in Patients With Early Stage Uterine Malignancy Receiving Radiotherapy

dc.authorscopusid 56233673300
dc.authorscopusid 55193140200
dc.authorscopusid 13005120600
dc.contributor.author Karaca, F.
dc.contributor.author Menteş, S.
dc.contributor.author Keskin, S.
dc.date.accessioned 2025-05-10T17:01:24Z
dc.date.available 2025-05-10T17:01:24Z
dc.date.issued 2018
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Karaca F., Adana City Education and Training Hospital, Department of Radiation Oncology, Turkey; Menteş S., Adana City Education and Training Hospital, Department of Radiation Oncology, Turkey; Keskin S., Van Yüzüncü Yıl University Medical Faculty, Department of Biostatistics, Turkey en_US
dc.description.abstract Surgery is the primary choice of treatment for this disorder. Radiotherapy is an important step of treatment in this cancer after surgery due to the stage of the disease. Lack of prospective randomised data for survival limits the use of adjuvant radiotherapy. Hovewer adjuvant radiotherapy is suggested for high risk patients to reduce locoregional recurrence. The aim of this study is to define the statistical difference of hemogram, transaminases, kidney function tests and electrolyte changes in patients before starting radiotherapy, the end of radiotherapy, with the onset of acute side effects, and three months after finishing radiotherapy with the onset of chronic side effects. 18 patients with early stage endometrial malignancy attending to Adana Numune Training and Research Hospital have been included. This study has assessed the changes in hemogram, blood transaminases, urea, creatinin and electrolyte values of patients before radiotherapy, at the last week of radiotherapy and three months after radiotherapy. The values were statistically significant for AST, Ca, LDH, urea, Hb and HTC values before treatment, at the end of the treatment and three months after treatment (p<0.05). The effect of radiotheraphy seen as lower values of hemoglobin and hematocrite in endometrial malignancy patients resolved and become normal after three months of the radiotherapy. © 2018, Yuzuncu Yil Universitesi Tip Fakultesi. All rights reserved. en_US
dc.identifier.doi 10.5505/ejm.2018.96158
dc.identifier.endpage 152 en_US
dc.identifier.issn 1301-0883
dc.identifier.issue 3 en_US
dc.identifier.scopus 2-s2.0-85051377757
dc.identifier.scopusquality Q4
dc.identifier.startpage 146 en_US
dc.identifier.trdizinid 287601
dc.identifier.uri https://doi.org/10.5505/ejm.2018.96158
dc.identifier.uri https://hdl.handle.net/20.500.14720/5157
dc.identifier.volume 23 en_US
dc.identifier.wosquality N/A
dc.language.iso en en_US
dc.publisher Yuzuncu Yil Universitesi Tip Fakultesi en_US
dc.relation.ispartof Eastern Journal of Medicine en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Endometrium Cancer en_US
dc.subject Hemogram en_US
dc.subject Radiotheraphy en_US
dc.title Evaluation of Hematologic and Biochemical Parameters in Patients With Early Stage Uterine Malignancy Receiving Radiotherapy en_US
dc.type Article en_US

Files